title: Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert.
authors.forename: M J
authors.initials: MJ
authors.lastname: Otero
authors.forename: A
authors.initials: A
authors.lastname: Fuertes
authors.forename: R
authors.initials: R
authors.lastname: Sánchez
authors.forename: G
authors.initials: G
authors.lastname: Luna
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects; D004347:Drug Interactions; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008691:Methadone / Q000378:metabolism / Q000627:therapeutic use*; D009294:Narcotics / Q000378:metabolism / Q000627:therapeutic use; D019829:Nevirapine / Q000009:adverse effects*; D009293:Opioid-Related Disorders / Q000150:complications / Q000534:rehabilitation; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D015819:Substance Abuse, Intravenous / Q000150:complications* / Q000534:rehabilitation; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
chemical_list: D019380:Anti-HIV Agents; D009294:Narcotics; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine; D008691:Methadone